Acumen Wealth Advisors’s Celestica CLS Stock Holding History

Acumen Wealth Advisors’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6K	Sell	29 -2	-6%	-$751	﹤0.01%	323
2026 Q1	$8.73K	Buy	31 +15	+94%	+$4.35K	﹤0.01%	324
2025 Q4	$4.73K	Buy	+16	New	+$4.82K	﹤0.01%	385

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Acumen Wealth Advisors's CLS Position: Q2 2026 in Review

Acumen Wealth Advisors reduced its Celestica (CLS) stake by 6.5% in Q2 2026, selling an estimated $751 and leaving 29 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

Acumen Wealth Advisors first reported a position in CLS in Q4 2025 and has held it in 3 quarters since. 873 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

Acumen Wealth Advisors held 29 shares of Celestica worth $10.6K as of Q2 2026.
Acumen Wealth Advisors sold 2 Celestica shares in Q2 2026, an estimated $751.
Celestica made up ﹤0.01% of Acumen Wealth Advisors's portfolio in Q2 2026, its #323 holding.
Acumen Wealth Advisors first reported a position in Celestica in Q4 2025 and has held it in 3 quarters since.
873 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Acumen Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.